Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Baxter
Accenture
Chinese Patent Office
Federal Trade Commission

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 9,255,132

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,255,132
Title:Angiopoietin derived peptides
Abstract: Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.
Inventor(s): Kliger; Yossef (Rishon LeZion, IL), Borukhov; Itamar (Ramat-HaSharon, IL), Levy; Ofer (Moshav Mesilat Zion, IL), Tiran; Zohar (Oranit, IL), Wool; Assaf (Kiryat-Ono, IL), Schreiber; Ehud (Ramat-Gan, IL), Amir; Anat (Kibbuttz Kfar Aza, IL), Levine; Zurit (Herzlia, IL), Toporik; Amir (Gan-Shomron, IL)
Assignee: Compugen Ltd. (Tel-Aviv, IL)
Application Number:13/920,103
Patent Claims:see list of patent claims

Details for Patent 9,255,132

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial Compugen Ltd. (Tel-Aviv, IL) 2028-07-21 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial Compugen Ltd. (Tel-Aviv, IL) 2028-07-21 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Try a Free Trial Compugen Ltd. (Tel-Aviv, IL) 2028-07-21 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Argus Health
AstraZeneca
QuintilesIMS
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.